RNU6-782P

Across TCGA pan-cancer cohorts, RNU6-782P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-782P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-782P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-782P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

ACC, CESC, and LUAD are the cancer types where RNU6-782P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.667	<.001	135	view →
CESC	DFS	Tertile	II,III,IV	0.273	0.720	.002	78	view →
LUAD	OS	Tertile	III,IV	0.153	0.663	.004	54	view →
SARC	OS	Tertile	All	0.310	0.749	.001	36	view →
LAML	DFS	Tertile	All	0.195	0.583	.010	18	view →
STAD	OS	Tertile	IV	0.797	0.302	.042	18	view →
LGG	DFS	Tertile	All	0.164	0.734	<.001	18	view →
MESO	DFS	Tertile	III,IV	0.078	0.376	.012	9	view →
BLCA	DFS	Tertile	III,IV	0.178	0.497	.025	9	view →
GBM	DFS	Tertile	All	0.094	0.245	.041	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-782P–ACC (DFS)

Open the ACC breakdown →